List of Minolira drug patents

Minolira is owned by Epi Hlth.

Minolira contains Minocycline Hydrochloride.

Minolira has a total of 1 drug patent out of which 0 drug patents have expired.

Minolira was authorised for market use on 08 May, 2017.

Minolira is available in tablet, extended release;oral dosage forms.

The generics of Minolira are possible to be released after 07 April, 2036.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11103517 EPI HLTH Pharmaceutical compositions for minocycline
Apr, 2036

(13 years from now)

Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient

Market Authorisation Date: 08 May, 2017

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in